The current financial score of SeaStar Medical Holding Corp is 6.59. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 615.00K, representing a year-over-year increase of 81.95%, while its net profit experienced a year-over-year increase of 86.31%.
The current valuation score of SeaStar Medical Holding Corp is 5.84. Its current P/E ratio is -0.06, which is -39.22% below the recent high of -0.04 and -10065.78% above the recent low of -6.51.
The current earnings forecast score of SeaStar Medical Holding Corp is 8.00. The average price target is 10.00, with a high of 12.00 and a low of 8.00.
The current price momentum score of SeaStar Medical Holding Corp is 4.92. Currently, the stock price is trading between the resistance level at 3.86 and the support level at 3.02, making it suitable for range-bound swing trading.
The current institutional shareholding score of SeaStar Medical Holding Corp is 3.00. The latest institutional shareholding proportion is 2.37%, representing a quarter-over-quarter decrease of 23.40%.
The current risk assessment score of SeaStar Medical Holding Corp is 2.50. The company's beta value is -1.03. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.